by Marina Chenery | May 22, 2019 | Webinars
Do We Need to Change the Definition of Drug-Like Properties? In this webinar Mike Shultz (Novartis) presented; two decades have passed since the Rule of Five (Ro5) ushered in the concept of “drug-like” properties. Examination of oral drug parameters approved before...